Patents by Inventor Pi-Tsan Huang

Pi-Tsan Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nerve damage preventing and nerve protecting compounds, preparation method thereof, pharmaceutical composition thereof, and their use
    Patent number: 11987566
    Abstract: The present invention provides a novel compound for effectively preventing nerve damage and protecting nerves, and a preparation method thereof. Besides, the present invention also provides a pharmaceutical composition comprising the novel compound, and a use of the novel compound for preventing nerve damage and protecting nerves.
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: May 21, 2024
    Assignee: GENHEALTH PHARMA CO., LTD.
    Inventors: Lain-Tze Lee, Hui-Ping Tsai, Yi-Wen Lin, Shu-Fen Huang, Shih-Hung Liu, Chin-Wei Liu, Pi-Tsan Huang, Mei-Hui Chen
  • NERVE DAMAGE PREVENTING AND NERVE PROTECTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND THEIR USE
    Publication number: 20230242501
    Abstract: The present invention provides a novel compound for effectively preventing nerve damage and protecting nerves, and a preparation method thereof. Besides, the present invention also provides a pharmaceutical composition comprising the novel compound, and a use of the novel compound for preventing nerve damage and protecting nerves.
    Type: Application
    Filed: January 28, 2022
    Publication date: August 3, 2023
    Inventors: LAIN-TZE LEE, HUI-PING TSAI, YI-WEN LIN, SHU-FEN HUANG, Shih-Hung LIU, Chin-Wei LIU, PI-TSAN HUANG, MEI-HUI CHEN
  • Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition
    Patent number: 11124472
    Abstract: The present invention discloses a novel 3-aryl-2-propen-1-one series derivative and the synthesis processes thereof. Besides, the present invention also discloses the series derivative as a pharmaceutical composition and their use for promoting myocardial regeneration.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: September 21, 2021
    Assignee: GENHEALTH PHARMA CO., LTD.
    Inventors: Lain-Tze Lee, Hui-Ping Tsai, Shu-Fen Huang, Yi-Wen Lin, Pi-Tsan Huang, Ying-Ying Wu, Mei-Hui Chen, Li-Jie Hsu
  • MYOCARDIAL REGENERATION PROMOTING COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION, AND THEIR USE
    Publication number: 20200317602
    Abstract: The present invention discloses a novel 3-aryl-2-propen-1-one series derivative and the synthesis processes thereof. Besides, the present invention also discloses the series derivative as a pharmaceutical composition and their use for promoting myocardial regeneration.
    Type: Application
    Filed: April 8, 2019
    Publication date: October 8, 2020
    Applicant: GENHEALTH PHARMA CO., LTD.
    Inventors: Lain-Tze LEE, Hui-Ping TSAI, Shu-Fen HUANG, Yi-Wen LIN, Pi-Tsan HUANG, Ying-Ying WU, Mei-Hui CHEN, Li-Jie HSU
  • Hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
    Patent number: 7332615
    Abstract: The present invention discloses hydrophilic derivatives of 4,8-dihydrobenzodithiophene-4,8-diones, which are active as anticancer agents, along with pharmaceutical formulations containing the same.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: February 19, 2008
    Assignees: Industrial Technology Research Institute, Yung Shin Pharm. Ind. Co., Ltd.
    Inventors: Pi-Tsan Huang, Yen-Fang Wen, Wuu-Chian Shin, Mei-Hwai Chen, Sheng-Chu Kuo, Kuo-Hsiung Lee
  • Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
    Publication number: 20060069041
    Abstract: The present invention discloses hydrophilic derivatives of 4,8-dihydrobenzodithiophene-4,8-diones, which are active as anticancer agents, along with pharmaceutical formulations containing the same.
    Type: Application
    Filed: September 28, 2005
    Publication date: March 30, 2006
    Applicants: Industrial Technology Research Institute, YUNG SHIN PHARM. IND. CO., LTD.
    Inventors: Pi-Tsan Huang, Yen-Fang Wen, Wuu-Chian Shin, Mei-Hwai Chen, Sheng-Chu Kuo, Kuo-Hsiung Lee